(Q48374881)

English

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

0 references

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

neurodegeneration

1 reference

based on heuristic

inferred from title

author name string

O'Shea E

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

Granados R

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

Esteban B

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

Colado MI

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

Green AR

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

publication date

1 July 1998

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

Neuropharmacology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

37

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

919-926

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Ecstasy and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

The action of some amines related to adrenaline. Cyclohexylalkylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Ion trap tandem mass spectrometric evidence for the metabolism of 3,4-(methylenedioxy)methamphetamine to the potent neurotoxins 2,4,5-trihydroxymethamphetamine and 2,4,5-trihydroxyamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900029-X

7 January 2021

Identifiers

10.1016/S0028-3908(98)00029-X

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776387

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48374881&oldid=2165527928"